Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01711658
Title	TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. (TRYHARD)
Acronym	TRYHARD
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Radiation Therapy Oncology Group
Indications	laryngeal squamous cell carcinoma head and neck squamous cell carcinoma
Therapies	Cisplatin + Lapatinib + Radiotherapy Cisplatin + Radiotherapy
Age Groups:	senior \| adult
Covered Countries	USA \| CAN